President Trump announces the nomination of Dr Bhattacharya to Director of the National Institutes of Health.
Bhattacharya has called for shifting the agency’s focus toward funding more innovative research and reducing the influence of some of its longest-serving career officials, among other ideas.
Trump earlier this month selected Kennedy to lead the Department of Health and Human Services, which oversees NIH and other health agencies. Kennedy has played a central role in choosing top health-care staff and deputies for the next administration, including Marty Makary, a Johns Hopkins surgeon and writer whom Trump announced to lead the Food and Drug Administration, and Dave Weldon, an internal medicine physician and former GOP congressman whom Trump selected to run the Centers for Disease Control and Prevention.
Bhattacharya emerged as a prominent critic of the federal government’s covid-19 response, co-writing an October 2020 open letter known as the Great Barrington Declaration that called for rolling back coronavirus-related shutdowns while keeping “focused protections” for vulnerable populations, such as older Americans. The proposal won support from Republican politicians and some Americans eager to resume daily life but was rebuked by public health experts, including then-NIH Director Francis S. Collins, as premature and dangerous as the covid-19 virus continued to spread and vaccines were not yet available.
Bhattacharya has called for rolling back the power of some of the 27 institutes and centers that constitute NIH, saying that some career civil servants wrongly shaped national policies at the height of the pandemic and did not tolerate dissent. Bhattacharya and other critics have singled out Anthony S. Fauci, the infectious-disease expert who led one of NIH’s centers for 38 years and helped steer the nation’s coronavirus response before leaving the federal government in December 2022.
Trump Appoints Controversial Covid Critic Bhattacharya To NIH
Be the first to reply to this general discussion.
